TickerFactsScreenerDevelopers

SANGAMO THERAPEUTICS, INC (SGMO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$19.40M2010: -$24.93M2011: -$35.82M2012: -$22.20M2013: -$26.71M2014: -$26.78M2015: -$46.86M2016: -$72.56M2017: -$56.36M2018: -$77.15M2019: -$105.18M2020: -$129.55M2021: -$183.34M2022: -$201.28M2023: -$274.00M2024: -$103.97M2025: -$121.24M-$121.24M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$121.24M-16.6%
2024-$103.97M+62.1%
2023-$274.00M-36.1%
2022-$201.28M-9.8%
2021-$183.34M-41.5%
2020-$129.55M-23.2%
2019-$105.18M-36.3%
2018-$77.15M-36.9%
2017-$56.36M+22.3%
2016-$72.56M-54.9%
2015-$46.86M-75.0%
2014-$26.78M-0.3%
2013-$26.71M-20.3%
2012-$22.20M+38.0%
2011-$35.82M-43.7%
2010-$24.93M-28.5%
2009-$19.40M—